FDA plans to limit COVID-19 vaccines to high-risk groups
By Alice Park Senior Correspondent
Today, U.S. Food and Drug Administration leadership outlined a plan to follow other countries in restricting yearly COVID-19 vaccines to vulnerable populations, including seniors and those with weakened immune systems. The agency also proposed additional studies to justify the use of the vaccine in the general population.
Some experts doubt whether this approach is practical or even ethical, since COVID-19 can still cause severe illness. Here's what to know.
As a provider, your expertise changes lives – and taking insurance makes care accessible to those who need it most. Headway makes it seamless. Start accepting insurance with ease so you can focus on what you do best – providing quality care.
Join 50,000+ providers building their best practices and expanding their reach with Headway.
Simplify insurance with streamlined billing, credentialing, and compliance
Earn more with higher rates, bi-weekly payments, and expert guidance
Access free continuing education to deepen your skillset and keep up your licensure
Manage a connected practice with EHR tools for scheduling, messaging, and documentation
The best part? It's all in one free, no-commitment platform. With Headway, taking insurance is easier than you think.
The social-media trend of "mouth-taping" comes with potential benefits and definite risks.
Are Muscle-Building Supplements a Good Idea?
You don't need to take muscle-building supplements like whey and creatine. But they can help some people.
Why Your Breakfast Should Start with a Vegetable
By changing the order in which you eat food, it's possible to eat carbs and have healthy blood sugar, too.
If you were forwarded this and want to sign up to receive it daily, click here. Today's newsletter was written by Alice Park and edited by Angela Haupt.
Administration officials say he was not interested in other topics | Email not displaying correctly? View it in your browser. Subscribe to TIME magazine WHAT TO KNOW NOW LISTEN ...
Comentarios
Publicar un comentario